Seeking Alpha

Edap (EDAP +3.4%) gains after saying the FDA has given the thumbs-up on a pre-market approval...

Edap (EDAP +3.4%) gains after saying the FDA has given the thumbs-up on a pre-market approval application for its Ablatherm Integrated Imaging HIFU device, a high-intensity utrasound treatment for low-risk, localized prostate cancer.
Comments (3)
  • Local164
    , contributor
    Comments (3) | Send Message
     
    This is good news for our wallets as well as many men with this cancer!
    29 Mar 2013, 04:24 PM Reply Like
  • BobKusnirik
    , contributor
    Comments (4) | Send Message
     
    The question is whether Medicare will continue to pay for the tests and procedures under Obama Care.
    22 Jun 2013, 03:00 PM Reply Like
  • BobKusnirik
    , contributor
    Comments (4) | Send Message
     
    The question is whether Medicare will continue to cover the tests and treatments for this disease under Obama Care.
    22 Jun 2013, 03:05 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|